876175-63-2

Upstream product

• 876175-58-5 (3aR,4aS,5R,7aS,7bR)-7-Allyl-5-benzyloxy-2,2-dimethyl-hexahydro-[1,3]dioxolo[4',5':4,5]furo[3,2-b]pyrrole 
• 252052-99-6 3-deoxy-3-allylamino-1,2:5,6-di-O-isopropylidene-α-D-glucofuranose 
• 252053-07-9 (R)-1-((3aR,5S,6S,6aR)-6-Allylamino-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-5-yl)-ethane-1,2-diol 
• 876175-57-4 (3aR,4aS,5R,7aS,7bR)-7-Allyl-2,2-dimethyl-hexahydro-[1,3]dioxolo[4',5':4,5]furo[3,2-b]pyrrol-5-ol 

Downstream Products

• 876175-65-4 Acetic acid (1S,2R,8S,8aR)-8-acetoxy-2-benzyloxy-1,2,3,5,8,8a-hexahydro-indolizin-1-yl ester 
• 876175-64-3 Acetic acid (2R,3S,4R)-2-((S)-1-acetoxy-allyl)-1-allyl-4-benzyloxy-pyrrolidin-3-yl ester 

Relevant academic research and scientific papers

Divergent cycloaddition and ring-closing metathesis approaches to indolizidine and pyrrolo[1,2-a]azepine skeletons from a chiral precursor: An expeditious route to (-)-8-epi-swainsonine triacetate

A divergent strategy for the synthesis of diverse azabicyclic ring systems has been developed in which a chiral N-allylpyrrolidine derivative, obtained from a carbohydrate precursor was converted to (-)-8-ep/-swainsonine triacetate by RCM and to a pyrrolo